FIELD: medicine.
SUBSTANCE: method involves introducing hypotensive means by means of instillations. Eye drops of emoxipin are instilled 20-30 min later twice a day during 4-8 weeks. The treatment course is repeated in 2-3 months.
EFFECT: improved vision function; normalized hemodynamic values.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING OPEN ANGLE GLAUCOMA | 1999 |
|
RU2173123C2 |
METHOD FOR TREATING PRIMARY OPEN ANGLE GLAUCOMA | 1997 |
|
RU2144343C1 |
METHOD FOR TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 0 |
|
SU1648452A1 |
METHOD OF SELECTING PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA FOR SELECTIVE LASER TRABECULOPLASTY | 2019 |
|
RU2726462C1 |
ANTIGLAUCOMATOUS PREPARATION | 2000 |
|
RU2191013C2 |
ANTIGLAUCOMATOUS AGENT | 1997 |
|
RU2128486C1 |
METHOD OF PREVENTING THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796891C1 |
METHOD FOR PREDICTING CLINICAL VARIANTS OF GLAUCOMA IN PATIENTS WITH MYOPIC REFRACTION | 2003 |
|
RU2242914C1 |
METHOD FOR LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA FOLLOWING MINIMALLY INVASIVE NONPENETRATING DEEP SCLERECTOMY | 2014 |
|
RU2576811C1 |
METHOD FOR COMPLEX TREATING ISCHEMIC VARIANT OF GLAUCOMA IN PATIENTS WITH MYOPIC REFRACTION | 2004 |
|
RU2281759C2 |
Authors
Dates
2005-01-10—Published
2003-07-15—Filed